Becton Dickinson announces expansion of BD MAX System menu

BD announced the expansion of its respiratory and sexually transmitted infection diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX System. The addition of these new assays to the BD MAX System portfolio enables clinical laboratories to detect a broad range of pathogens quickly and accurately using a fully automated molecular platform. The newly certified assays include: VIASURE Respiratory Virus Extended Mix Real Time PCR Detection Kit for BD MAX System: Detects multiple respiratory viruses, including SARS-CoV-2, flu (A and B), RSV, parainfluenza, human coronavirus, metapneumovirus, and adenovirus, from a single nasopharyngeal swab. VIASURE HSV-1, HSV-2 & Treponema pallidum Assay for BD MAX System: Identifies the presence of herpes simplex viruses (HSV-1 and HSV-2) and the bacteria that causes syphilis (Treponema pallidum) using anogenital and oral skin lesion swabs.